Is your contention that if there is efficacy along with safety they do not report it? If it was not effective would you want to know? If yes, why would you not want to know if it was positive?
The fact that the trial monitored the patients and benefited the patients should be something to celebrate, right? Or because you are a non-holder you don’t care?
I am a non holder but appreciate the info and this Ann had triggered my interest in the company. Apologies that the sentiment was incorrect before and I have corrected it to None, Not held.
- Forums
- ASX - By Stock
- CHM
- Ann: CORE NK Platform Phase 1 Clinical Data Presentation
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

Ann: CORE NK Platform Phase 1 Clinical Data Presentation, page-30
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $11.72K | 2.783M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2757364 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 15260220 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 2757364 | 0.004 |
43 | 28003271 | 0.003 |
15 | 13950505 | 0.002 |
10 | 50600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 15260220 | 25 |
0.006 | 13343479 | 16 |
0.007 | 3200000 | 3 |
0.008 | 8542434 | 6 |
0.009 | 2327672 | 4 |
Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |